US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lantern Pharma Inc.

3.32

-0.1100-3.21%

Post-market: 3.13-0.1893-5.70%19:31 EDT

Volume:61.19K

Turnover:204.07K

Market Cap:35.81M

PE:-1.80

High:3.43

Open:3.28

Low:3.25

Close:3.43

Loading ...

Overview Company News Filings

Leslie W. Kreis, 10% Owner, Reports Disposal of Lantern Pharma Inc. Common Shares

Lantern Pharma Announces Promising Preclinical Data for LP-184 in Pediatric Brain Cancer, Plans Phase I Clinical Trial for Late 2025

Lantern Pharma's Lp-184 Shows Promising in Vivo Activity in Atypical Teratoid Rhabdoid Tumors (Atrt) at Sno Pediatric Conference, Further Validating Rare Pediatric Disease Designation and Pathway to Clinical Trials

THOMSON REUTERS

Lantern Pharma Advances AI-Driven Cancer Therapies

Lantern Pharma Inc reports results for the quarter ended March 31 - Earnings Summary

Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates

THOMSON REUTERS

Lantern Pharma Q1 Net Income USD -4.5 Million

THOMSON REUTERS

Press Release: Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates

Lantern Pharma Reports Q1 2025 Results: R&D Expenses Down to $3.3M, Cash Reserves at $19.7M

Lantern Pharma Q1 EPS $(0.42) Beats $(0.49) Estimate

Lantern Pharma Inc: Qtrly Shr Loss $0.42

THOMSON REUTERS

Lantern Pharma Inc expected to post a loss of 49 cents a share - Earnings Preview

Press Release: Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET

Lantern Advances Drug Candidate Lp-184 With Ind Clearance for Phase 1B/2 Clinical Trial in Triple Negative Breast Cancer (Tnbc)

THOMSON REUTERS

Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC)

EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial

Lantern Pharma Inc expected to post a loss of 49 cents a share - Earnings Preview

Lantern Pharma initiated with a Buy at Lake Street

LTRN: 2024 Financial Results

Zacks Small Cap Research

Lantern Pharma Inc Qtrly EPS $-0.54

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LTRN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LTRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTRN\",,,,,undefined,":{"symbol":"LTRN","market":"US","secType":"STK","nameCN":"Lantern Pharma Inc.","latestPrice":3.32,"timestamp":1749240000000,"preClose":3.43,"halted":0,"volume":61185,"hourTrading":{"tag":"盘后","latestPrice":3.1307,"preClose":3.32,"latestTime":"19:31 EDT","volume":676,"amount":2199.765,"timestamp":1749252686460},"delay":0,"floatShares":8086080,"shares":10784725,"eps":-1.845127,"marketStatus":"Market Closed","change":-0.11,"latestTime":"06-06 16:00:00 EDT","open":3.28,"high":3.43,"low":3.2501,"amount":204072.459738,"amplitude":0.052449,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.845127,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1591848000000,"exchange":"NASDAQ","adjPreClose":3.43,"preHourTrading":{"tag":"盘前","latestPrice":3.4299,"preClose":3.365,"latestTime":"08:30 EDT","volume":1,"amount":3.4299,"timestamp":1749213030055},"postHourTrading":{"tag":"盘后","latestPrice":3.1307,"preClose":3.32,"latestTime":"19:31 EDT","volume":676,"amount":2199.765,"timestamp":1749252686460},"volumeRatio":1.5076064124914796,"impliedVol":0.2385,"impliedVolPercentile":0.124},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTRN\",,,,,undefined,":{"symbol":"LTRN","floatShares":8086080,"roa":"-43.68%","roe":"-75.66%","lyrEps":-1.930923,"volumeRatio":1.5076064124914796,"shares":10784725,"dividePrice":0,"high":3.43,"amplitude":0.052449,"preClose":3.43,"low":3.2501,"week52Low":2.55,"pbRate":"2.13","week52High":6.118,"institutionHeld":0,"latestPrice":3.32,"eps":-1.845127,"divideRate":0,"volume":61185,"delay":0,"ttmEps":-1.845127,"open":3.28,"prevYearClose":3.19,"prevWeekClose":3.05,"prevMonthClose":3.05,"prevQuarterClose":3.54,"fiveDayClose":3.05,"twentyDayClose":3.86,"sixtyDayClose":3.84},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LTRN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2539139062","title":"Leslie W. Kreis, 10% Owner, Reports Disposal of Lantern Pharma Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2539139062","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539139062?lang=en_us&edition=fundamental","pubTime":"2025-05-30 09:54","pubTimestamp":1748570053,"startTime":"0","endTime":"0","summary":"Leslie W. Kreis, a 10% Owner, reported a disposal of common shares of Lantern Pharma Inc. on May 27, 2025. The form was filed by more than one reporting person, including Aaron Glenn Louis Fletcher and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantern Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL8lsW0Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Leslie W. Kreis, 10% Owner, Reports Disposal of Lantern Pharma Inc. Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2539500582","title":"Lantern Pharma Announces Promising Preclinical Data for LP-184 in Pediatric Brain Cancer, Plans Phase I Clinical Trial for Late 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2539500582","media":"Reuters","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539500582?lang=en_us&edition=fundamental","pubTime":"2025-05-29 20:30","pubTimestamp":1748521850,"startTime":"0","endTime":"0","summary":"Lantern Pharma Announces Promising Preclinical Data for LP-184 in Pediatric Brain Cancer, Plans Phase I Clinical Trial for Late 2025. DALLAS-- Lantern Pharma Inc. , a clinical-stage biopharmaceutical company, has announced promising preclinical data for their drug candidate LP-184 in the treatment of atypical teratoid rhabdoid tumors , a rare pediatric brain cancer. The data was presented at the Society for Neuro-Oncology's 8th Biennial Pediatric Neuro-Oncology Conference held in May 2025. LP-184 has demonstrated significant anti-tumor activity across multiple ATRT cell lines and has received Rare Pediatric Disease Designation from the FDA. Lantern Pharma plans to initiate a pediatric clinical trial for LP-184 in late 2025 or early 2026, following the completion of an ongoing Phase I trial in adult solid tumors and pending necessary approvals and funding.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL3blXCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2539250717","title":"Lantern Pharma's Lp-184 Shows Promising in Vivo Activity in Atypical Teratoid Rhabdoid Tumors (Atrt) at Sno Pediatric Conference, Further Validating Rare Pediatric Disease Designation and Pathway to Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2539250717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539250717?lang=en_us&edition=fundamental","pubTime":"2025-05-29 20:30","pubTimestamp":1748521801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nTUA1VCMVX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2535336545","title":"Lantern Pharma Advances AI-Driven Cancer Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2535336545","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535336545?lang=en_us&edition=fundamental","pubTime":"2025-05-16 11:57","pubTimestamp":1747367852,"startTime":"0","endTime":"0","summary":"Lantern Pharma, Inc. ( ($LTRN) ) has released its Q1 earnings. Here is a breakdown of the information Lantern Pharma, Inc. presented to its investo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lantern-pharma-advances-ai-driven-cancer-therapies-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lantern-pharma-advances-ai-driven-cancer-therapies-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2535825073","title":"Lantern Pharma Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535825073","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535825073?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:31","pubTimestamp":1747315916,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc reports results for the quarter ended March 31 - Earnings SummaryLantern Pharma Inc LTRN.OQ reported a quarterly adjusted loss of 42 cents per share for the quarter ended March 31, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nL8N3RN1MF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2535404458","title":"Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2535404458","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535404458?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:45","pubTimestamp":1747313100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA4GQHX2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2535409898","title":"Lantern Pharma Q1 Net Income USD -4.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535409898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535409898?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:45","pubTimestamp":1747313100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nPLX001FDC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2535840479","title":"Press Release: Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2535840479","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535840479?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:45","pubTimestamp":1747313100,"startTime":"0","endTime":"0","summary":"-- Completion of LP-184 Phase 1a clinical trial enrollment with 62-65. patients across a range of solid tumors expected by end of June 2025.-- Additional patient data readout from the HARMONIC Trial evaluating. LP-300 in never-smokers with non-small cell lung cancer . anticipated in Q3 2025, including initial readout for patients from the. -- Strengthened AI intellectual property portfolio with PCT publication of. application; favorable PCT search report indicated no significant prior. -- Expanded RADR platform with innovative AI-powered module to improve. -- Planning commercial availability and launch of select RADR AI modules. 31, 2025, providing expected operating runway through at least May 15,\"This quarter represents a pivotal inflection point in our clinical and technological development. As we approach full enrollment in our LP-184 Phase 1a trial and prepare for an additional data readout for our LP-300 Harmonic Trial, including initial data from our Asian expansion cohort, we a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ADC","BK4585","LU0347712357.USD","LU1093756168.USD","BK4099","MTD","BK4588","SRC","BK4139","R","BK4232","BK4567","LU2413666699.HKD","LTRN","03160","IE00BFXG0V08.USD","BK4533","BK4555","IE00BYQQ9H92.USD","LU1721428933.USD","BK4080","TM","BK4231","BK4022","LU2413666426.HKD","BK4604","LU1093756325.SGD","BK4548"],"gpt_icon":0},{"id":"2535847024","title":"Lantern Pharma Reports Q1 2025 Results: R&D Expenses Down to $3.3M, Cash Reserves at $19.7M","url":"https://stock-news.laohu8.com/highlight/detail?id=2535847024","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535847024?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:33","pubTimestamp":1747312395,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc. has announced its financial results for the first quarter of 2025. The company reported cash, cash equivalents, and marketable securities of approximately $19.7 million as of March 31, 2025, a decrease from approximately $24.0 million at December 31, 2024. Research and development expenses were approximately $3.3 million for the quarter ended March 31, 2025, compared to approximately $4.3 million for the same period in 2024. Significant operational updates include the anticipated completion of LP-184 Phase 1a clinical trial enrollment with 62-65 patients across a range of solid tumors by the end of June 2025. Additionally, a data readout from the HARMONIC Trial evaluating LP-300 in never-smokers with non-small cell lung cancer is expected in Q3 2025, including initial data from the Asian expansion cohort. Lantern Pharma has also strengthened its AI intellectual property portfolio with the PCT publication of a proprietary blood-brain barrier penetration prediction pa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL2P57WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2535085847","title":"Lantern Pharma Q1 EPS $(0.42) Beats $(0.49) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535085847","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535085847?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:32","pubTimestamp":1747312355,"startTime":"0","endTime":"0","summary":"Lantern Pharma Q1 EPS $(0.42) Beats $(0.49) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45435188/lantern-pharma-q1-eps-0-42-beats-0-49-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2535477288","title":"Lantern Pharma Inc: Qtrly Shr Loss $0.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2535477288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535477288?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:32","pubTimestamp":1747312349,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nFWN3RN1VE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2535762770","title":"Lantern Pharma Inc  expected to post a loss of 49 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2535762770","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535762770?lang=en_us&edition=fundamental","pubTime":"2025-05-13 22:40","pubTimestamp":1747147220,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc  expected to post a loss of49cents a share - Earnings Preview Lantern Pharma Inc LTRN.OQ LTRN.O is expected to show no change in quarterly revenue when it reports  results on May 15","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL8N3RL1X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Lantern Pharma Inc  expected to post a loss of 49 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2533182084","title":"Press Release: Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2533182084","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533182084?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:33","pubTimestamp":1746707580,"startTime":"0","endTime":"0","summary":"Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET. -- Webcast to be held Thursday, May 15th, 9:00 a.m. ET, register for the. webcast here, or at the link provided below.Lantern Pharma Inc. , an artificial intelligence  company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning  platform with multiple clinical stage drug programs, today announced that it will host its first quarter 2025 operating and financial results webcast on Thursday, May 15, 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time.Our lead development programs include a Phase 2 clinical program and multiple Phase 1 clinical trials. We have also established a wholly-owned subsidiary, Starlight Therapeutics, to focus exclusively on the clinical execution of our promising therapies for CNS and brain cancers, many of which have no effective treatment options. Our AI-driven pipeline of innovative product candidates i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ET","LTRN"],"gpt_icon":0},{"id":"2533581441","title":"Lantern Advances Drug Candidate Lp-184 With Ind Clearance for Phase 1B/2 Clinical Trial in Triple Negative Breast Cancer (Tnbc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533581441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533581441?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:55","pubTimestamp":1746449700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA2MYFNL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2533399587","title":"Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533399587","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533399587?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:55","pubTimestamp":1746449700,"startTime":"0","endTime":"0","summary":"Figure 1: Preclinical PDX Tumor Models & LP-184 Tumor Volume Change. Figure 2: LP-184 Synergy with Olaparib in Treatment Resistant TNBC PDX Models.The FDA has cleared the investigational new drug  application of LP-184 in triple negative breast cancer  treatment – a novel small molecule advanced and developed with Lantern’s AI platform, RADR. The phase 1b/2 clinical trial plans to evaluate LP-184 in recurrent TNBC patients as both monotherapy and in combination with olaparib.This achievement follows the FDA’s Orphan Drug Designation for LP-184 in TNBC in 2023 and FDA Fast Track Designation for LP-184 in TNBC in 2024.DALLAS, May 05, 2025----Lantern Pharma Inc. , an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary AI platform, RADR, today announced that it has received clearance of its Investigational New Drug Application  from the U.S. Food and Drug Administration  for a Phase 1b/2 clinical trial for LP-184 in Triple Negative ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-advances-drug-candidate-lp-125500305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADC","BK4080","BK4231","LTRN","BK4139"],"gpt_icon":0},{"id":"2533873125","title":"EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2533873125","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533873125?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:31","pubTimestamp":1746448308,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration  on Monday cleared Lantern Pharma Inc.’s  Investigational New Drug Application  for a Phase 1b/2 trial for LP-184 in triple-negative breast cancer .Monotherapy Arm: An open-label study involving approximately 30 patients with advanced-stage TNBC, focusing on dose optimization to evaluate, enhance, and optimize safety and potential efficacy for TNBC patients.Combination Therapy: Evaluation of LP-184 in combination with olaparib in second-line settings for patients with advanced-stage TNBC harboring BRCA1 or BRCA2 alterations, with primary endpoints including safety and efficacy parameters that could support a pathway to regulatory approval.In preclinical studies, treating an animal model with BRCA-1 LOH and an HRD score of 63 resistant to the PARP inhibitor showed evidence of resensitization in combination with LP-184.In 2024, LP-184 received Fast Track Designations from the FDA for GBM andTNBC.Dose levels 7, 8, and 9 were cleared without safety con","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-lantern-advances-breast-cancer-123148984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LTRN","SSI","BK4139"],"gpt_icon":1},{"id":"2533043583","title":"Lantern Pharma Inc  expected to post a loss of 49 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533043583","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533043583?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:42","pubTimestamp":1746445325,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc  expected to post a loss of49cents a share - Earnings Preview Lantern Pharma Inc LTRN.OQ LTRN.O is expected to show no change in quarterly revenue when it reports  results on May 7 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL8N3RD0QI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2524249684","title":"Lantern Pharma initiated with a Buy at Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2524249684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524249684?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:47","pubTimestamp":1743598021,"startTime":"0","endTime":"0","summary":"Lake Street initiated coverage of Lantern Pharma (LTRN) with a Buy rating and $25 price target Lantern’s Response Algorithm for Drug Positioning an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantern-pharma-initiated-with-a-buy-at-lake-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantern-pharma-initiated-with-a-buy-at-lake-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2522501367","title":"LTRN: 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522501367","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522501367?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:20","pubTimestamp":1743157200,"startTime":"0","endTime":"0","summary":"Lantern Pharma, Inc  reports 2024 results highlighting several achievements including progress on its HARMONIC, LP-184 and LP-284 trials, a portfolio of expedited designations in multiple indications and advances in the RADR platform with modules that offer predictive algorithms for blood brain barrier  penetration and antibody drug conjugate  design.On March 27th, 2025, Lantern announced 2024 financial and operational results, filed its Form 10-K with the SEC and hosted a video webcast to review accomplishments. A slide deck was included to guide the discussion. In the financial sphere, Lantern generated no revenues in 2024 and incurred operating expense of $22.2 million, producing a net loss of  million or  per share.General & administrative expenses were $6.1 million, rising 2% from $6.0 million. Higher professional fees were partially offset by lower wage and benefit costs, a decrease in insurance expense and a decline in stock","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ltrn-2024-financial-results-102000980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","NQmain","MNQmain","TSYW.SI","USJW.SI","IE00BN0W2W23.USD","ADC","LTRN","JAZZ","CMRX","BK4231","BK4007","LU0889565916.HKD","NVIW.SI","LU0823416689.USD","BK4533","BK4583","QLD","LU0320765992.SGD","PSQ","USAW.SI","TQQQ","LU0109394709.USD","SQQQ","BK4139","QID","BK4532","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4080"],"gpt_icon":1},{"id":"2522309537","title":"Lantern Pharma Inc Qtrly EPS $-0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2522309537","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522309537?lang=en_us&edition=fundamental","pubTime":"2025-03-28 05:12","pubTimestamp":1743109969,"startTime":"0","endTime":"0","summary":"March 27 (Reuters) - Lantern Pharma Inc ::*LANTERN PHARMA INC QTRLY EPS $-0.54  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 27-MAR-202520:01:00.123 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nRSD9W4BY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LTRN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"LTRN","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2025-03-27","symbol":"LTRN","fiscalQuarterEnding":"2024/12","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2024-11-07","symbol":"LTRN","fiscalQuarterEnding":"2024/09","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.42},{"market":"US","date":"2024-08-08","symbol":"LTRN","fiscalQuarterEnding":"2024/06","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2024-05-09","symbol":"LTRN","fiscalQuarterEnding":"2024/03","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LTRN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LTRN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LTRN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LTRN","date":"2025-06-05","current":-1.812177,"percent":0.969845,"low":-49.754346,"twenty":-21.392124,"median":-4.08311,"eighty":-2.737661,"high":-1.33893,"avg":-10.521923,"sd":11.735736,"marketCap":36020981},"quantilePoints":[{"date":"2020-06-12","current":-37.409733,"twenty":-39.359566,"median":-38.38465,"eighty":-36.899593,"marketCap":91709511},{"date":"2020-06-19","current":-33.224824,"twenty":-39.359566,"median":-36.899593,"eighty":-32.920529,"marketCap":81450258},{"date":"2020-06-26","current":-29.67408,"twenty":-38.579633,"median":-33.465813,"eighty":-30.394407,"marketCap":72745650},{"date":"2020-07-02","current":-33.300912,"twenty":-37.374225,"median":-33.123374,"eighty":-30.465455,"marketCap":81636786},{"date":"2020-07-10","current":-32.184964,"twenty":-37.165675,"median":-33.1741,"eighty":-30.790028,"marketCap":78901052},{"date":"2020-07-17","current":-33.478449,"twenty":-36.899593,"median":-32.933157,"eighty":-31.368191,"marketCap":82072016},{"date":"2020-07-24","current":-31.851447,"twenty":-36.261035,"median":-32.793662,"eighty":-31.345466,"marketCap":78083440},{"date":"2020-07-31","current":-28.842302,"twenty":-33.661132,"median":-32.540038,"eighty":-31.053798,"marketCap":76591222},{"date":"2020-08-07","current":-27.394157,"twenty":-33.453087,"median":-32.210326,"eighty":-29.81611,"marketCap":72745650},{"date":"2020-08-14","current":-25.240087,"twenty":-33.341492,"median":-32.077173,"eighty":-28.986296,"marketCap":67025480},{"date":"2020-08-21","current":-38.866924,"twenty":-33.661132,"median":-32.083514,"eighty":-28.857053,"marketCap":103211778},{"date":"2020-08-28","current":-39.967373,"twenty":-36.511038,"median":-32.223007,"eighty":-28.986296,"marketCap":106134039},{"date":"2020-09-04","current":-33.24761,"twenty":-36.899593,"median":-32.66685,"eighty":-29.267466,"marketCap":88289593},{"date":"2020-09-11","current":-45.04817,"twenty":-36.899593,"median":-32.793662,"eighty":-29.26828,"marketCap":119626181},{"date":"2020-09-18","current":-38.562545,"twenty":-38.866924,"median":-32.9712,"eighty":-29.290676,"marketCap":102403493},{"date":"2020-09-25","current":-42.987755,"twenty":-39.359566,"median":-33.224824,"eighty":-29.67408,"marketCap":114154713},{"date":"2020-10-02","current":-47.998076,"twenty":-39.382028,"median":-33.274261,"eighty":-30.384229,"marketCap":127459706},{"date":"2020-10-09","current":-47.085171,"twenty":-40.388822,"median":-33.478449,"eighty":-30.409674,"marketCap":125035473},{"date":"2020-10-16","current":-46.312516,"twenty":-41.770236,"median":-33.711344,"eighty":-30.688578,"marketCap":122983673},{"date":"2020-10-23","current":-40.974167,"twenty":-41.465857,"median":-34.558783,"eighty":-31.01829,"marketCap":108807597},{"date":"2020-10-30","current":-25.461466,"twenty":-41.442443,"median":-34.757801,"eighty":-30.688578,"marketCap":93885412},{"date":"2020-11-06","current":-27.569203,"twenty":-41.184891,"median":-33.715886,"eighty":-29.290676,"marketCap":101657383},{"date":"2020-11-13","current":-25.832427,"twenty":-40.974167,"median":-33.491805,"eighty":-28.916055,"marketCap":95253279},{"date":"2020-11-20","current":-27.063346,"twenty":-40.974167,"median":-33.300912,"eighty":-28.479745,"marketCap":99792110},{"date":"2020-11-27","current":-27.653512,"twenty":-40.974167,"median":-33.224824,"eighty":-27.569203,"marketCap":101968262},{"date":"2020-12-04","current":-25.798704,"twenty":-40.936705,"median":-33.098013,"eighty":-27.140684,"marketCap":95128928},{"date":"2020-12-11","current":-30.941582,"twenty":-40.496525,"median":-32.844388,"eighty":-26.678895,"marketCap":114092537},{"date":"2020-12-18","current":-31.44744,"twenty":-40.295167,"median":-32.692257,"eighty":-26.989154,"marketCap":115957811},{"date":"2020-12-24","current":-32.290534,"twenty":-40.229608,"median":-32.427759,"eighty":-27.12135,"marketCap":119066599},{"date":"2020-12-31","current":-32.459153,"twenty":-40.107856,"median":-32.526601,"eighty":-27.182053,"marketCap":119688357},{"date":"2021-01-08","current":-31.852125,"twenty":-39.901815,"median":-32.413226,"eighty":-27.286725,"marketCap":117450029},{"date":"2021-01-15","current":-24.179962,"twenty":-39.634897,"median":-32.24625,"eighty":-27.102015,"marketCap":89160054},{"date":"2021-01-22","current":-25.984185,"twenty":-39.377536,"median":-32.197645,"eighty":-26.635054,"marketCap":95812861},{"date":"2021-01-29","current":-25.343433,"twenty":-39.359566,"median":-32.083514,"eighty":-26.232054,"marketCap":93450182},{"date":"2021-02-05","current":-29.069912,"twenty":-39.359566,"median":-32.047625,"eighty":-26.206761,"marketCap":107191027},{"date":"2021-02-12","current":-31.127064,"twenty":-39.359566,"median":-32.037606,"eighty":-26.232054,"marketCap":114776471},{"date":"2021-02-19","current":-32.526601,"twenty":-39.359566,"median":-31.852125,"eighty":-26.279268,"marketCap":119937060},{"date":"2021-02-26","current":-29.963593,"twenty":-39.007407,"median":-31.641351,"eighty":-26.504432,"marketCap":110486343},{"date":"2021-03-05","current":-25.208537,"twenty":-38.866924,"median":-31.436771,"eighty":-26.279268,"marketCap":92952776},{"date":"2021-03-12","current":-35.863529,"twenty":-38.866924,"median":-31.442106,"eighty":-26.279268,"marketCap":211888545},{"date":"2021-03-19","current":-40.230675,"twenty":-39.007407,"median":-31.835263,"eighty":-26.504432,"marketCap":237690471},{"date":"2021-03-26","current":-35.371989,"twenty":-39.007407,"median":-31.868987,"eighty":-26.523765,"marketCap":208984432},{"date":"2021-04-01","current":-37.602825,"twenty":-38.895021,"median":-32.047625,"eighty":-26.523765,"marketCap":222164636},{"date":"2021-04-09","current":-32.381247,"twenty":-38.866924,"median":-32.083514,"eighty":-26.604703,"marketCap":191314558},{"date":"2021-04-16","current":-29.258566,"twenty":-38.866924,"median":-32.047625,"eighty":-26.665406,"marketCap":172865170},{"date":"2021-04-23","current":-31.321428,"twenty":-38.698345,"median":-31.852125,"eighty":-26.689012,"marketCap":185052947},{"date":"2021-04-30","current":-28.406926,"twenty":-38.581276,"median":-31.656371,"eighty":-26.894727,"marketCap":167833519},{"date":"2021-05-07","current":-22.155216,"twenty":-38.248499,"median":-31.436771,"eighty":-26.523765,"marketCap":174654202},{"date":"2021-05-14","current":-18.353937,"twenty":-37.716257,"median":-31.351316,"eighty":-26.216879,"marketCap":144687924},{"date":"2021-05-21","current":-20.552438,"twenty":-37.508972,"median":-31.195828,"eighty":-26.149432,"marketCap":162019167},{"date":"2021-05-28","current":-21.446023,"twenty":-37.424888,"median":-31.101771,"eighty":-26.017909,"marketCap":169063478},{"date":"2021-06-04","current":-21.524034,"twenty":-37.366783,"median":-31.022091,"eighty":-25.930125,"marketCap":169678458},{"date":"2021-06-11","current":-22.098481,"twenty":-37.274577,"median":-30.941582,"eighty":-25.818938,"marketCap":174206944},{"date":"2021-06-18","current":-21.403471,"twenty":-37.227708,"median":-30.614831,"eighty":-25.738872,"marketCap":168728035},{"date":"2021-06-25","current":-21.644597,"twenty":-37.029643,"median":-30.431937,"eighty":-25.62334,"marketCap":170628881},{"date":"2021-07-02","current":-20.708461,"twenty":-36.899593,"median":-30.384684,"eighty":-25.476146,"marketCap":163249126},{"date":"2021-07-09","current":-20.33968,"twenty":-36.890456,"median":-30.352795,"eighty":-25.221157,"marketCap":160341949},{"date":"2021-07-16","current":-18.439041,"twenty":-36.864694,"median":-30.182797,"eighty":-24.793735,"marketCap":145358811},{"date":"2021-07-23","current":-19.531199,"twenty":-36.581934,"median":-30.078022,"eighty":-22.705551,"marketCap":153968525},{"date":"2021-07-30","current":-15.403585,"twenty":-36.105763,"median":-29.947911,"eighty":-22.138196,"marketCap":144274103},{"date":"2021-08-06","current":-16.346905,"twenty":-35.960314,"median":-29.731278,"eighty":-21.726863,"marketCap":153109493},{"date":"2021-08-13","current":-15.045362,"twenty":-35.897559,"median":-29.424012,"eighty":-21.566586,"marketCap":140918891},{"date":"2021-08-20","current":-13.636352,"twenty":-35.725617,"median":-29.281466,"eighty":-21.409145,"marketCap":127721725},{"date":"2021-08-27","current":-16.788713,"twenty":-35.490294,"median":-29.267262,"eighty":-21.278653,"marketCap":157247588},{"date":"2021-09-03","current":-16.955884,"twenty":-35.417362,"median":-29.086774,"eighty":-21.074405,"marketCap":158813353},{"date":"2021-09-10","current":-16.10809,"twenty":-35.363879,"median":-29.010896,"eighty":-20.824769,"marketCap":150872686},{"date":"2021-09-17","current":-14.125923,"twenty":-35.256515,"median":-28.916055,"eighty":-20.685767,"marketCap":132307181},{"date":"2021-09-24","current":-14.531909,"twenty":-34.881047,"median":-28.820644,"eighty":-20.50705,"marketCap":136109754},{"date":"2021-10-01","current":-12.776617,"twenty":-34.574126,"median":-28.611675,"eighty":-20.294292,"marketCap":119669217},{"date":"2021-10-08","current":-13.182603,"twenty":-34.544735,"median":-28.462884,"eighty":-19.760978,"marketCap":123471790},{"date":"2021-10-15","current":-11.952704,"twenty":-34.44971,"median":-27.952719,"eighty":-19.576588,"marketCap":111952230},{"date":"2021-10-22","current":-12.036289,"twenty":-34.275477,"median":-27.705292,"eighty":-19.20497,"marketCap":112735113},{"date":"2021-10-29","current":-12.191519,"twenty":-34.173387,"median":-27.569203,"eighty":-18.370958,"marketCap":114189038},{"date":"2021-11-05","current":-9.842875,"twenty":-33.997191,"median":-27.187561,"eighty":-17.888706,"marketCap":115346279},{"date":"2021-11-12","current":-9.308247,"twenty":-33.714069,"median":-26.945313,"eighty":-16.795878,"marketCap":109081108},{"date":"2021-11-19","current":-8.582681,"twenty":-33.666475,"median":-26.65023,"eighty":-16.497358,"marketCap":100578375},{"date":"2021-11-26","current":-8.554041,"twenty":-33.505162,"median":-26.523765,"eighty":-16.346905,"marketCap":100242741},{"date":"2021-12-03","current":-7.2843,"twenty":-33.504591,"median":-26.279268,"eighty":-15.928978,"marketCap":85362959},{"date":"2021-12-10","current":-7.704365,"twenty":-33.478449,"median":-26.194958,"eighty":-15.475229,"marketCap":90285594},{"date":"2021-12-17","current":-7.341582,"twenty":-33.351637,"median":-26.152804,"eighty":-15.105066,"marketCap":86034228},{"date":"2021-12-23","current":-6.978799,"twenty":-33.311057,"median":-26.11908,"eighty":-14.656093,"marketCap":81782861},{"date":"2021-12-31","current":-7.618442,"twenty":-33.25827,"median":-26.017909,"eighty":-14.381456,"marketCap":89278691},{"date":"2022-01-07","current":-6.711485,"twenty":-33.229381,"median":-25.950292,"eighty":-14.202344,"marketCap":78650276},{"date":"2022-01-14","current":-6.940611,"twenty":-33.224824,"median":-25.874582,"eighty":-13.674562,"marketCap":81335349},{"date":"2022-01-21","current":-5.842715,"twenty":-33.19439,"median":-25.815565,"eighty":-13.464405,"marketCap":68469372},{"date":"2022-01-28","current":-6.033654,"twenty":-33.082795,"median":-25.798704,"eighty":-13.165886,"marketCap":70706933},{"date":"2022-02-04","current":-6.434624,"twenty":-33.00801,"median":-25.714394,"eighty":-12.7599,"marketCap":75405812},{"date":"2022-02-11","current":-6.596922,"twenty":-32.951779,"median":-25.630085,"eighty":-12.36182,"marketCap":77307739},{"date":"2022-02-18","current":-6.377343,"twenty":-32.874823,"median":-25.571068,"eighty":-12.213013,"marketCap":74734544},{"date":"2022-02-25","current":-6.100482,"twenty":-32.824098,"median":-25.473699,"eighty":-12.067335,"marketCap":71490080},{"date":"2022-03-04","current":-5.346275,"twenty":-32.763263,"median":-25.240087,"eighty":-11.589705,"marketCap":62651713},{"date":"2022-03-11","current":-5.964441,"twenty":-32.697339,"median":-25.054193,"eighty":-9.89061,"marketCap":73738551},{"date":"2022-03-18","current":-6.06908,"twenty":-32.63773,"median":-24.78699,"eighty":-9.669121,"marketCap":75032210},{"date":"2022-03-25","current":-6.226039,"twenty":-32.56707,"median":-23.472542,"eighty":-9.273878,"marketCap":76972698},{"date":"2022-04-01","current":-6.304518,"twenty":-32.507746,"median":-22.665836,"eighty":-8.714429,"marketCap":77942942},{"date":"2022-04-08","current":-6.11268,"twenty":-32.47134,"median":-22.141033,"eighty":-8.309639,"marketCap":75571234},{"date":"2022-04-14","current":-5.99932,"twenty":-32.455781,"median":-21.970826,"eighty":-8.080514,"marketCap":74169771},{"date":"2022-04-22","current":-6.01676,"twenty":-32.436479,"median":-21.687148,"eighty":-7.763555,"marketCap":74385381},{"date":"2022-04-29","current":-5.22141,"twenty":-32.411349,"median":-21.637505,"eighty":-7.50388,"marketCap":64552444},{"date":"2022-05-06","current":-4.746858,"twenty":-32.399323,"median":-21.446023,"eighty":-7.295756,"marketCap":66610324},{"date":"2022-05-13","current":-4.515304,"twenty":-32.363104,"median":-21.410563,"eighty":-7.230838,"marketCap":63361039},{"date":"2022-05-20","current":-4.631081,"twenty":-32.283789,"median":-21.375103,"eighty":-7.138233,"marketCap":64985682},{"date":"2022-05-27","current":-4.330061,"twenty":-32.252586,"median":-21.21908,"eighty":-7.009349,"marketCap":60761612},{"date":"2022-06-03","current":-4.413883,"twenty":-32.235688,"median":-21.112702,"eighty":-6.91197,"marketCap":61937853},{"date":"2022-06-10","current":-4.160254,"twenty":-32.210326,"median":-21.03469,"eighty":-6.740126,"marketCap":58378804},{"date":"2022-06-17","current":-3.755035,"twenty":-32.184964,"median":-20.786473,"eighty":-6.654203,"marketCap":52692557},{"date":"2022-06-24","current":-3.890108,"twenty":-32.161504,"median":-20.708461,"eighty":-6.500434,"marketCap":54587972},{"date":"2022-07-01","current":-4.337779,"twenty":-32.115171,"median":-20.665909,"eighty":-6.423168,"marketCap":60869922},{"date":"2022-07-08","current":-4.468993,"twenty":-32.094937,"median":-20.552438,"eighty":-6.333427,"marketCap":62711183},{"date":"2022-07-15","current":-4.160254,"twenty":-32.085385,"median":-20.424784,"eighty":-6.243603,"marketCap":58378804},{"date":"2022-07-22","current":-3.897827,"twenty":-32.075905,"median":-20.282945,"eighty":-6.231271,"marketCap":54696282},{"date":"2022-07-29","current":-3.959574,"twenty":-32.062919,"median":-19.775871,"eighty":-6.154674,"marketCap":55562758},{"date":"2022-08-05","current":-4.214284,"twenty":-32.045621,"median":-19.71559,"eighty":-6.100482,"marketCap":59136970},{"date":"2022-08-12","current":-4.266648,"twenty":-31.946552,"median":-19.580843,"eighty":-6.074312,"marketCap":69155596},{"date":"2022-08-19","current":-3.742088,"twenty":-31.865615,"median":-19.531199,"eighty":-6.039432,"marketCap":60653303},{"date":"2022-08-26","current":-3.802295,"twenty":-31.851718,"median":-19.048947,"eighty":-6.008464,"marketCap":61629171},{"date":"2022-09-02","current":-3.474796,"twenty":-31.841737,"median":-18.439041,"eighty":-5.953459,"marketCap":56320924},{"date":"2022-09-09","current":-3.563002,"twenty":-31.692149,"median":-18.311386,"eighty":-5.923279,"marketCap":57750609},{"date":"2022-09-16","current":-3.347832,"twenty":-31.465463,"median":-17.956789,"eighty":-5.846534,"marketCap":54263044},{"date":"2022-09-23","current":-3.16741,"twenty":-31.443172,"median":-16.955884,"eighty":-5.814926,"marketCap":51338688},{"date":"2022-09-30","current":-3.194139,"twenty":-31.421553,"median":-16.681247,"eighty":-5.711562,"marketCap":51771926},{"date":"2022-10-07","current":-3.374561,"twenty":-31.391233,"median":-16.526016,"eighty":-5.645613,"marketCap":54696282},{"date":"2022-10-14","current":-3.214186,"twenty":-31.357051,"median":-16.382728,"eighty":-5.408473,"marketCap":52096855},{"date":"2022-10-21","current":-3.133998,"twenty":-31.322155,"median":-16.299142,"eighty":-5.121538,"marketCap":50797141},{"date":"2022-10-28","current":-2.873389,"twenty":-31.271188,"median":-15.95883,"eighty":-4.705178,"marketCap":46573072},{"date":"2022-11-04","current":-2.873389,"twenty":-31.195301,"median":-15.582696,"eighty":-4.573964,"marketCap":46573072},{"date":"2022-11-11","current":-3.53139,"twenty":-31.167532,"median":-15.439407,"eighty":-4.510673,"marketCap":50919517},{"date":"2022-11-18","current":-4.005756,"twenty":-31.10683,"median":-15.140888,"eighty":-4.48443,"marketCap":57759452},{"date":"2022-11-25","current":-3.802456,"twenty":-31.066361,"median":-15.045362,"eighty":-4.468993,"marketCap":54828052},{"date":"2022-12-02","current":-3.840104,"twenty":-31.024372,"median":-14.627435,"eighty":-4.414099,"marketCap":55370904},{"date":"2022-12-09","current":-3.960578,"twenty":-31.016438,"median":-14.424442,"eighty":-4.387177,"marketCap":57108030},{"date":"2022-12-16","current":-4.322,"twenty":-30.99554,"median":-14.299065,"eighty":-4.362479,"marketCap":62319409},{"date":"2022-12-23","current":-4.231644,"twenty":-30.890981,"median":-14.221449,"eighty":-4.331605,"marketCap":61016564},{"date":"2022-12-30","current":-4.547888,"twenty":-30.688578,"median":-13.958752,"eighty":-4.322,"marketCap":65576521},{"date":"2023-01-06","current":-4.178937,"twenty":-30.664948,"median":-13.684115,"eighty":-4.2961,"marketCap":60256572},{"date":"2023-01-13","current":-4.12623,"twenty":-30.588305,"median":-13.582618,"eighty":-4.228632,"marketCap":59496579},{"date":"2023-01-20","current":-3.9154,"twenty":-30.498766,"median":-13.278129,"eighty":-4.214284,"marketCap":56456608},{"date":"2023-01-27","current":-4.005756,"twenty":-30.439507,"median":-13.170662,"eighty":-4.193895,"marketCap":57759452},{"date":"2023-02-03","current":-4.299411,"twenty":-30.418579,"median":-12.901995,"eighty":-4.200454,"marketCap":61993698},{"date":"2023-02-10","current":-4.465062,"twenty":-30.394954,"median":-12.752735,"eighty":-4.206043,"marketCap":64382247},{"date":"2023-02-17","current":-4.103641,"twenty":-30.384593,"median":-12.472746,"eighty":-4.181621,"marketCap":59170868},{"date":"2023-02-24","current":-3.9154,"twenty":-30.377849,"median":-12.340779,"eighty":-4.153392,"marketCap":56456608},{"date":"2023-03-03","current":-4.171407,"twenty":-30.355891,"median":-12.227342,"eighty":-4.141289,"marketCap":60148001},{"date":"2023-03-10","current":-3.23766,"twenty":-30.329741,"median":-12.125845,"eighty":-4.12749,"marketCap":46684186},{"date":"2023-03-17","current":-3.576568,"twenty":-30.26415,"median":-12.036289,"eighty":-4.099206,"marketCap":51570940},{"date":"2023-03-24","current":-3.437568,"twenty":-30.176471,"median":-11.648214,"eighty":-4.081052,"marketCap":49019535},{"date":"2023-03-31","current":-3.677398,"twenty":-30.136702,"median":-11.200436,"eighty":-4.068388,"marketCap":52439503},{"date":"2023-04-06","current":-3.761149,"twenty":-30.085978,"median":-9.852422,"eighty":-4.059969,"marketCap":53633777},{"date":"2023-04-14","current":-3.844899,"twenty":-30.04453,"median":-9.709218,"eighty":-4.007326,"marketCap":54828052},{"date":"2023-04-21","current":-3.738308,"twenty":-29.963593,"median":-9.594655,"eighty":-3.990697,"marketCap":53308066},{"date":"2023-04-28","current":-3.631716,"twenty":-29.947911,"median":-9.308247,"eighty":-3.990448,"marketCap":51788080},{"date":"2023-05-05","current":-3.806831,"twenty":-29.920953,"median":-9.126856,"eighty":-3.962604,"marketCap":54285200},{"date":"2023-05-12","current":-4.178189,"twenty":-29.788476,"median":-8.668604,"eighty":-3.962604,"marketCap":58519445},{"date":"2023-05-19","current":-3.643318,"twenty":-29.67408,"median":-8.491986,"eighty":-3.960578,"marketCap":51028088},{"date":"2023-05-26","current":-3.674325,"twenty":-29.474597,"median":-8.219898,"eighty":-3.959574,"marketCap":51462369},{"date":"2023-06-02","current":-4.116175,"twenty":-29.434129,"median":-8.057601,"eighty":-3.958337,"marketCap":57650882},{"date":"2023-06-09","current":-4.255706,"twenty":-29.397638,"median":-7.857115,"eighty":-3.95332,"marketCap":59605149},{"date":"2023-06-16","current":-4.581279,"twenty":-29.31075,"median":-7.704365,"eighty":-3.958337,"marketCap":64165106},{"date":"2023-06-23","current":-4.13943,"twenty":-29.279623,"median":-7.618442,"eighty":-3.959574,"marketCap":57976593},{"date":"2023-06-30","current":-3.992147,"twenty":-29.270665,"median":-7.456145,"eighty":-3.959976,"marketCap":55913756},{"date":"2023-07-07","current":-3.96114,"twenty":-29.268076,"median":-7.341582,"eighty":-3.960578,"marketCap":55479474},{"date":"2023-07-14","current":-4.030905,"twenty":-29.265523,"median":-7.269979,"eighty":-3.959775,"marketCap":56456608},{"date":"2023-07-21","current":-3.643318,"twenty":-29.224208,"median":-7.227019,"eighty":-3.953116,"marketCap":51028088},{"date":"2023-07-28","current":-3.488284,"twenty":-29.086774,"median":-7.181671,"eighty":-3.941001,"marketCap":48856680},{"date":"2023-08-04","current":-3.658822,"twenty":-29.083402,"median":-7.083815,"eighty":-3.9154,"marketCap":51245228},{"date":"2023-08-11","current":-3.80683,"twenty":-29.046305,"median":-7.012213,"eighty":-3.903079,"marketCap":54285200},{"date":"2023-08-18","current":-3.285114,"twenty":-28.94887,"median":-6.940611,"eighty":-3.893814,"marketCap":46845562},{"date":"2023-08-25","current":-3.582375,"twenty":-28.93268,"median":-6.768766,"eighty":-3.88239,"marketCap":51084488},{"date":"2023-09-01","current":-3.445178,"twenty":-28.906358,"median":-6.740126,"eighty":-3.874911,"marketCap":49128060},{"date":"2023-09-08","current":-3.361335,"twenty":-28.867569,"median":-6.701938,"eighty":-3.859234,"marketCap":47932466},{"date":"2023-09-15","current":-3.193649,"twenty":-28.842302,"median":-6.625563,"eighty":-3.847634,"marketCap":45541277},{"date":"2023-09-22","current":-2.8659,"twenty":-28.816312,"median":-6.511,"eighty":-3.842981,"marketCap":40867590},{"date":"2023-09-29","current":-2.629616,"twenty":-28.728847,"median":-6.484585,"eighty":-3.822188,"marketCap":37498188},{"date":"2023-10-06","current":-2.416198,"twenty":-28.668005,"median":-6.453718,"eighty":-3.818334,"marketCap":34454856},{"date":"2023-10-13","current":-2.431442,"twenty":-28.608896,"median":-6.372569,"eighty":-3.808049,"marketCap":34672237},{"date":"2023-10-20","current":-2.355221,"twenty":-28.574172,"median":-6.310514,"eighty":-3.80683,"marketCap":33585333},{"date":"2023-10-27","current":-2.103693,"twenty":-28.526959,"median":-6.304518,"eighty":-3.802392,"marketCap":29998550},{"date":"2023-11-03","current":-2.088448,"twenty":-28.459511,"median":-6.243583,"eighty":-3.796462,"marketCap":29781169},{"date":"2023-11-10","current":-2.674822,"twenty":-28.422564,"median":-6.234759,"eighty":-3.786034,"marketCap":40541519},{"date":"2023-11-17","current":-2.760875,"twenty":-28.134402,"median":-6.215769,"eighty":-3.775032,"marketCap":41845804},{"date":"2023-11-24","current":-2.891389,"twenty":-27.886995,"median":-6.18163,"eighty":-3.764808,"marketCap":43823969},{"date":"2023-12-01","current":-2.832586,"twenty":-27.775873,"median":-6.121399,"eighty":-3.757481,"marketCap":42932708},{"date":"2023-12-08","current":-2.696335,"twenty":-27.715647,"median":-6.100482,"eighty":-3.742088,"marketCap":40867590},{"date":"2023-12-15","current":-2.976008,"twenty":-27.619788,"median":-6.08652,"eighty":-3.728574,"marketCap":45106516},{"date":"2023-12-22","current":-2.92581,"twenty":-27.569203,"median":-6.060914,"eighty":-3.710855,"marketCap":44345683},{"date":"2023-12-29","current":-3.148115,"twenty":-27.569203,"median":-6.04292,"eighty":-3.682077,"marketCap":47715085},{"date":"2024-01-05","current":-2.997521,"twenty":-27.464175,"median":-6.03856,"eighty":-3.676169,"marketCap":45432587},{"date":"2024-01-12","current":-2.897126,"twenty":-27.286725,"median":-6.01676,"eighty":-3.652498,"marketCap":43910921},{"date":"2024-01-19","current":-2.753704,"twenty":-27.193069,"median":-5.99932,"eighty":-3.636357,"marketCap":41737113},{"date":"2024-01-26","current":-3.004693,"twenty":-27.12135,"median":-5.960859,"eighty":-3.595258,"marketCap":45541277},{"date":"2024-02-02","current":-3.033377,"twenty":-27.016133,"median":-5.947001,"eighty":-3.581467,"marketCap":45976039},{"date":"2024-02-09","current":-2.976008,"twenty":-26.844141,"median":-5.899997,"eighty":-3.557152,"marketCap":45106516},{"date":"2024-02-16","current":-2.875613,"twenty":-26.68564,"median":-5.852262,"eighty":-3.548697,"marketCap":43584850},{"date":"2024-02-23","current":-2.775217,"twenty":-26.665406,"median":-5.842715,"eighty":-3.544265,"marketCap":42063184},{"date":"2024-03-01","current":-3.449301,"twenty":-26.604703,"median":-5.815138,"eighty":-3.535733,"marketCap":52280082},{"date":"2024-03-08","current":-4.768784,"twenty":-26.523765,"median":-5.720282,"eighty":-3.534794,"marketCap":72279116},{"date":"2024-03-15","current":-5.270761,"twenty":-26.519898,"median":-5.711562,"eighty":-3.534822,"marketCap":79887444},{"date":"2024-03-22","current":-6.076744,"twenty":-26.459399,"median":-5.720282,"eighty":-3.535733,"marketCap":96994155},{"date":"2024-03-28","current":-6.581457,"twenty":-26.279268,"median":-5.814075,"eighty":-3.53892,"marketCap":105050148},{"date":"2024-04-05","current":-4.858703,"twenty":-26.220251,"median":-5.815247,"eighty":-3.540353,"marketCap":77552359},{"date":"2024-04-12","current":-4.488581,"twenty":-26.203389,"median":-5.798762,"eighty":-3.544265,"marketCap":71644631},{"date":"2024-04-19","current":-3.882925,"twenty":-26.186527,"median":-5.711562,"eighty":-3.544265,"marketCap":61977439},{"date":"2024-04-26","current":-3.67431,"twenty":-26.152804,"median":-5.676682,"eighty":-3.547966,"marketCap":58647629},{"date":"2024-05-03","current":-3.700511,"twenty":-26.152804,"median":-5.592109,"eighty":-3.544265,"marketCap":59065839},{"date":"2024-05-10","current":-4.590252,"twenty":-26.135942,"median":-5.449964,"eighty":-3.547966,"marketCap":73267462},{"date":"2024-05-17","current":-3.767359,"twenty":-26.11908,"median":-5.375831,"eighty":-3.548301,"marketCap":66059062},{"date":"2024-05-24","current":-3.822581,"twenty":-26.102218,"median":-5.270761,"eighty":-3.54929,"marketCap":67027355},{"date":"2024-05-31","current":-3.865532,"twenty":-26.034771,"median":-5.222097,"eighty":-3.551368,"marketCap":67780471},{"date":"2024-06-07","current":-3.564879,"twenty":-26.017909,"median":-5.215024,"eighty":-3.554841,"marketCap":62508657},{"date":"2024-06-14","current":-3.337856,"twenty":-25.997675,"median":-5.047678,"eighty":-3.548167,"marketCap":58527899},{"date":"2024-06-21","current":-2.724279,"twenty":-25.970628,"median":-4.921059,"eighty":-3.541918,"marketCap":47769094},{"date":"2024-06-28","current":-2.785637,"twenty":-25.957071,"median":-4.879965,"eighty":-3.538123,"marketCap":48844974},{"date":"2024-07-05","current":-2.632243,"twenty":-25.920042,"median":-4.773258,"eighty":-3.534794,"marketCap":46155273},{"date":"2024-07-12","current":-2.577021,"twenty":-25.889758,"median":-4.677392,"eighty":-3.524417,"marketCap":45186981},{"date":"2024-07-15","current":-2.712008,"twenty":-25.886385,"median":-4.672877,"eighty":-3.516764,"marketCap":47553918},{"date":"2024-08-02","current":-2.49112,"twenty":-25.883013,"median":-4.668362,"eighty":-3.513777,"marketCap":43680748},{"date":"2024-08-09","current":-2.595428,"twenty":-25.866151,"median":-4.656049,"eighty":-3.486212,"marketCap":45509745},{"date":"2024-08-16","current":-2.602067,"twenty":-25.832427,"median":-4.631081,"eighty":-3.47183,"marketCap":46180670},{"date":"2024-08-23","current":-2.559609,"twenty":-25.798704,"median":-4.597393,"eighty":-3.454749,"marketCap":45427139},{"date":"2024-08-30","current":-2.450431,"twenty":-25.798704,"median":-4.580911,"eighty":-3.437634,"marketCap":43489489},{"date":"2024-09-06","current":-2.122898,"twenty":-25.798704,"median":-4.569333,"eighty":-3.425531,"marketCap":37676537},{"date":"2024-09-13","current":-2.298796,"twenty":-25.763894,"median":-4.550892,"eighty":-3.410889,"marketCap":40798307},{"date":"2024-09-20","current":-2.468628,"twenty":-25.722553,"median":-4.532829,"eighty":-3.385253,"marketCap":43812430},{"date":"2024-09-27","current":-2.329123,"twenty":-25.714394,"median":-4.518517,"eighty":-3.364857,"marketCap":41336544},{"date":"2024-10-04","current":-2.183553,"twenty":-25.660436,"median":-4.507586,"eighty":-3.349575,"marketCap":38753010},{"date":"2024-10-11","current":-2.056179,"twenty":-25.633457,"median":-4.492149,"eighty":-3.345103,"marketCap":36492417},{"date":"2024-10-18","current":-2.056179,"twenty":-25.616595,"median":-4.48443,"eighty":-3.321099,"marketCap":36492417},{"date":"2024-10-25","current":-2.092571,"twenty":-25.586244,"median":-4.468993,"eighty":-3.300188,"marketCap":37138301},{"date":"2024-10-31","current":-1.977328,"twenty":-25.569382,"median":-4.468993,"eighty":-3.280799,"marketCap":35093003},{"date":"2024-11-08","current":-2.074375,"twenty":-25.516614,"median":-4.453556,"eighty":-3.262859,"marketCap":36815359},{"date":"2024-11-15","current":-1.967789,"twenty":-25.471252,"median":-4.414423,"eighty":-3.237626,"marketCap":37568890},{"date":"2024-11-22","current":-1.666407,"twenty":-25.390646,"median":-4.399527,"eighty":-3.221873,"marketCap":31814938},{"date":"2024-11-29","current":-1.813277,"twenty":-25.302095,"median":-4.397296,"eighty":-3.196812,"marketCap":34618967},{"date":"2024-12-06","current":-1.977093,"twenty":-25.227467,"median":-4.376411,"eighty":-3.174092,"marketCap":37746537},{"date":"2024-12-13","current":-2.050528,"twenty":-25.147834,"median":-4.367817,"eighty":-3.139645,"marketCap":39148551},{"date":"2024-12-20","current":-1.813277,"twenty":-25.05471,"median":-4.348356,"eighty":-3.094682,"marketCap":34618967},{"date":"2024-12-27","current":-1.988391,"twenty":-25.002055,"median":-4.337419,"eighty":-3.077838,"marketCap":37962232},{"date":"2025-01-03","current":-1.864117,"twenty":-24.803852,"median":-4.33356,"eighty":-3.053811,"marketCap":35589592},{"date":"2025-01-10","current":-2.214345,"twenty":-24.790362,"median":-4.324687,"eighty":-3.033377,"marketCap":42276122},{"date":"2025-01-17","current":-2.033582,"twenty":-24.530689,"median":-4.300154,"eighty":-3.018391,"marketCap":38825010},{"date":"2025-01-24","current":-2.355566,"twenty":-24.294623,"median":-4.299187,"eighty":-3.008996,"marketCap":44972303},{"date":"2025-01-31","current":-2.717091,"twenty":-23.331059,"median":-4.280286,"eighty":-3.000867,"marketCap":51874527},{"date":"2025-02-07","current":-2.993884,"twenty":-22.705551,"median":-4.269116,"eighty":-2.987482,"marketCap":57159042},{"date":"2025-02-14","current":-2.728389,"twenty":-22.665836,"median":-4.259678,"eighty":-2.976008,"marketCap":52090221},{"date":"2025-02-21","current":-2.445947,"twenty":-22.484282,"median":-4.247217,"eighty":-2.968837,"marketCap":46697859},{"date":"2025-02-28","current":-2.253886,"twenty":-22.189258,"median":-4.231644,"eighty":-2.952498,"marketCap":43031052},{"date":"2025-03-07","current":-2.197398,"twenty":-22.143869,"median":-4.214284,"eighty":-2.93585,"marketCap":41952580},{"date":"2025-03-14","current":-2.112666,"twenty":-22.115502,"median":-4.209055,"eighty":-2.92581,"marketCap":40334871},{"date":"2025-03-21","current":-2.101368,"twenty":-21.996357,"median":-4.192657,"eighty":-2.899677,"marketCap":40119177},{"date":"2025-03-28","current":-2.101368,"twenty":-21.820477,"median":-4.18341,"eighty":-2.890529,"marketCap":40119177},{"date":"2025-04-04","current":-1.686637,"twenty":-21.746721,"median":-4.174798,"eighty":-2.875613,"marketCap":35050356},{"date":"2025-04-11","current":-1.577654,"twenty":-21.675801,"median":-4.160254,"eighty":-2.868896,"marketCap":32785564},{"date":"2025-04-17","current":-1.811188,"twenty":-21.655944,"median":-4.145382,"eighty":-2.864249,"marketCap":37638690},{"date":"2025-04-25","current":-1.878654,"twenty":-21.64176,"median":-4.141289,"eighty":-2.848075,"marketCap":39040704},{"date":"2025-05-02","current":-1.878654,"twenty":-21.609137,"median":-4.13943,"eighty":-2.830572,"marketCap":39040704},{"date":"2025-05-09","current":-2.003205,"twenty":-21.508432,"median":-4.127806,"eighty":-2.805336,"marketCap":41629038},{"date":"2025-05-16","current":-2.003205,"twenty":-21.446023,"median":-4.11117,"eighty":-2.797361,"marketCap":41629038},{"date":"2025-05-23","current":-1.817603,"twenty":-21.440349,"median":-4.106032,"eighty":-2.782825,"marketCap":36128828},{"date":"2025-05-30","current":-1.698238,"twenty":-21.417655,"median":-4.09536,"eighty":-2.760875,"marketCap":33756189},{"date":"2025-06-05","current":-1.812177,"twenty":-21.392124,"median":-4.08311,"eighty":-2.737661,"marketCap":36020981}],"updateTime":1749262912194}}}